Loading…
Ensysce Biosciences, Inc. is projected to rise to $0.3733 by 2027, a +24% move from its current price of $0.30. ENSC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.2832 | $0.2999 | $0.3176 | -0.04% |
| May 30 | $0.2764 | $0.2998 | $0.3251 | -0.07% |
| May 31 | $0.2714 | $0.2997 | $0.3309 | -0.11% |
| Jun 1 | $0.2671 | $0.2996 | $0.3359 | -0.15% |
| Jun 2 | $0.2634 | $0.2994 | $0.3404 | -0.19% |
| Jun 3 | $0.2601 | $0.2993 | $0.3444 | -0.22% |
| Jun 4 | $0.2571 | $0.2992 | $0.3482 | -0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2571 | $0.2992 | $0.3482 | -0.26% |
| Week 2 | $0.2409 | $0.2984 | $0.3698 | -0.52% |
| Week 3 | $0.2289 | $0.2977 | $0.3871 | -0.78% |
| Week 4 | $0.2192 | $0.2969 | $0.4021 | -1.04% |
| Week 5 | $0.211 | $0.2961 | $0.4156 | -1.29% |
| Week 6 | $0.2037 | $0.2954 | $0.4282 | -1.55% |
| Week 7 | $0.1972 | $0.2946 | $0.44 | -1.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company in the Healthcare sector that develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using the Trypsin Activated Abuse Protection (TAAP) platform and the Multi-Pill Abuse Resistance (MPAR) platform.
Ensysce Biosciences, Inc. (ENSC) trades at $0.3186 per share with a market cap of $4.68M and a rank of 5363. The company operates in healthcare research and development focused on opioid-related pain relief and overdose protection.
A major floor 62.4% below — a decisive break under it would weaken the trend.
The nearest floor, 7.7% below — buyers have tended to step in here.
The nearest ceiling, 78.3% above — a clean break opens room to run.
A major ceiling 213.0% above — clearing it would confirm fresh momentum.
Key ENSC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENSC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.312 | Sell | $0.308 | Sell |
| MA 10 | $0.3018 | Sell | $0.3154 | Sell |
| MA 20 | $0.3383 | Sell | $0.3423 | Sell |
| MA 50 | $0.4436 | Sell | $0.432 | Sell |
| MA 100 | $0.5477 | Sell | $0.6601 | Sell |
| MA 200 | $1.25 | Sell | $2.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.98 | Neutral |
| Stoch RSI (14) | 69.93 | Neutral |
| CCI (20) | -66.10 | Neutral |
| Williams %R (14) | -78.10 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -14.29 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 21.90 | Neutral |
| TRIX (15) | -1.53 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 47.94 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 0.32 | Sell |
| ADX (14) | 23.07 | Sell |
| ATR (14) | 0.02 | Info |
The 30-day technical picture shows sentiment as NEUTRAL with RSI14 at 40. The stock’s price is $0.3186, with a 50-day simple moving average (SMA) of $0.4482 and a 200-day SMA of $1.27. Support sits at $0.277 and resistance at $0.551, with a 30-day range from $0.2137 to $0.4751.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.277 | $0.30 | $0.5048 | 0% | Neutral | |
| $0.2687 | $0.3733 | $0.5614 | +24% | Bullish | |
| $0.2378 | $0.3507 | $0.5607 | +17% | Neutral | |
| $0.211 | $0.3276 | $0.549 | +9% | Neutral | |
| $0.1741 | $0.2833 | $0.4938 | -6% | Neutral | |
| $0.1831 | $0.3112 | $0.5614 | +4% | Neutral | |
| $0.2091 | $0.3706 | $0.689 | +24% | Bullish | |
| $0.2363 | $0.4361 | $0.8329 | +45% | Bullish | |
| $0.2417 | $0.4639 | $0.9082 | +55% | Bullish | |
| $0.2186 | $0.4362 | $0.8736 | +45% | Bullish | |
| $0.2643 | $0.5873 | $1.29 | +96% | Bullish | |
| $0.3685 | $0.8189 | $1.88 | +173% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.277 | $0.30 | $0.3592 | +0.00% |
| June 2026 | $0.2523 | $0.3026 | $0.376 | +0.86% |
| July 2026 | $0.2378 | $0.29 | $0.3696 | -4.16% |
| August 2026 | $0.2491 | $0.3078 | $0.40 | +6.15% |
| September 2026 | $0.2622 | $0.3277 | $0.4325 | +6.46% |
| October 2026 | $0.2557 | $0.3229 | $0.4321 | -1.49% |
| November 2026 | $0.2607 | $0.3321 | $0.4498 | +2.86% |
| December 2026 | $0.2867 | $0.3685 | $0.5048 | +10.96% |
Click any year to see its month-by-month ENSC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Ensysce Biosciences, Inc.'s 2026 outlook centres on $0.30, within a $0.277 to $0.5048 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ENSC could reach as high as $0.5614, with a base case around $0.3733 and support toward $0.2687 — roughly +24% from $0.30. Buyers look set to stay in control over this stretch.
Expect ENSC to range from $0.2378 to $0.5607 through 2028. The $0.3507 average target implies a +17% move from current prices. That is -6% versus the projected 2027 average. Price action looks broadly range-bound.
The ENSC price prediction for 2029 points to an average of $0.3276 (low $0.211, high $0.549) — a potential gain of +9% on today's $0.30. A consolidation phase looks the most probable path here.
In 2030, ENSC is projected to trade between $0.1741 and $0.4938, averaging $0.2833 — a potential decline of -6% from today's $0.30. That is -14% versus the projected 2029 average. Price action looks broadly range-bound.
Ensysce Biosciences, Inc.'s 2031 outlook centres on $0.3112, within a $0.1831 to $0.5614 range. That is up +10% on the projected 2030 average. That marks a +4% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, ENSC could reach as high as $0.689, with a base case around $0.3706 and support toward $0.2091 — roughly +24% from $0.30. Momentum favours further upside here.
Expect ENSC to range from $0.2363 to $0.8329 through 2033. The $0.4361 average target implies a +45% move from current prices. That is up +18% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ENSC price prediction for 2034 points to an average of $0.4639 (low $0.2417, high $0.9082) — a potential gain of +55% on today's $0.30. Momentum favours further upside here.
In 2035, ENSC is projected to trade between $0.2186 and $0.8736, averaging $0.4362 — a potential gain of +45% from today's $0.30. That is -6% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Ensysce Biosciences, Inc.'s 2040 outlook centres on $0.5873, within a $0.2643 to $1.29 range. That is up +35% on the projected 2035 average. That marks a +96% change versus current levels. Momentum favours further upside here.
By 2050, ENSC could reach as high as $1.88, with a base case around $0.8189 and support toward $0.3685 — roughly +173% from $0.30. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENSC today (≈ 3,333.333333 ENSC) could be worth
$2,729.82
+$1,729.82 (+173%) by 2050 · US Dollar
Based on the average projected ENSC price of $0.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENSCwould be worth at today's price.
$1,000 invested in ENSC on May 27, 2025 (≈ 420.168047 ENSC) would be worth
$126.05
-$873.95 (-87.4%) today · 0.13× · US Dollar
Based on a ENSC entry price of $2.38 vs. today's $0.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.31 | $967.74 | -3.2% |
| 1 month ago | $0.383 | $783.29 | -21.7% |
| 3 months ago | $0.395 | $759.49 | -24.1% |
| 6 months ago | $1.77 | $169.49 | -83.1% |
| 1 year ago | $2.38 | $126.05 | -87.4% |
| All time (5.0y) ago | $50,076 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENSC forecast.
Our base-case forecast reaches $0.60 around 2050.
Implied market cap at $0.60: $8.82M
The multi-year forecast depicts a mixed path. For 2026 the min, avg, and max are $0.277, $0.3186, and $0.5441 respectively, with a neutral sentiment. In 2027 the avg rises to $0.3926 (ROI 23.2%, sentiment BULLISH), while 2030 shows an avg of $0.2972 (ROI -6.7%, sentiment NEUTRAL).
Later years turn more bullish, with 2032 avg $0.3971 (ROI 24.6%), 2033 avg $0.4579 (ROI 43.7%), 2034 avg $0.4967 (ROI 55.9%), and 2035 avg $0.4655 (ROI 46.1%). The horizon extends to 2040 with avg $0.6265 (ROI 96.6%) and 2050 with avg $0.8786 (ROI 175.8%), both labeled BULLISH. These figures illustrate a potential upside in the long run but include periods of decline and notable volatility, and are not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows min $0.1826, avg $0.2972, max $0.5184 with ROI -6.7%.
The forecast indicates positive ROI in several years (e.g., 2027 23.2%, 2032 24.6%, 2033 43.7%, 2034 55.9%, 2040 96.6%, 2050 175.8%), but 2030 shows a negative ROI of -6.7%.
Yes. The forecast max price reaches $1.38 in 2040.
avg $0.8786, min $0.3954, max $2.02; ROI 175.8%.
Ensysce Biosciences, Inc. Community Discussion
0Share your Ensysce Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.